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Introduction
In countries with prevalent chronic hepatitis B and/
or C, such as Taiwan, treatment of active hepatitis,
the management of complications from liver cir-
rhosis, and the occurrence of hepatic tumors are
becoming a major concern. Hepatocellular carci-
noma (HCC) is the most common primary malig-
nancy and a leading cause of cancer mortality in
Taiwan. Detection of HCC and further differential
diagnosis between HCC and other benign or malig-
nant tumors are important issues in clinical practice.
With advances in ultrasonography (US) and the lab-
oratory examination of alpha-fetoprotein, the early
diagnosis of HCC has become feasible. However,
different kinds of tumors, both of a benign and a
malignant nature, may be found in the liver, and
the variable presentation of these tumors in imag-
ing studies increases the difficulty in the differen-
tial diagnosis of hepatic tumors. Among the many
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applications of US in the liver, the detection and
differentiation of focal hepatic lesions is the most
important issue.
By improving the resolution of images and
enhancing the signal-to-noise ratio, the sensitivity
of grayscale US is enough to detect hepatic tumors;
in addition, grayscale US also has some differential
diagnostic abilities [1]. However, with the use of
traditional grayscale US imaging, it is still difficult to
reach a specific diagnosis of hepatic tumor. Following
the development of US, color and power Doppler
US examinations have been added to the tradi-
tional grayscale images. Using color-coded imaging,
blood flow in organ vessels and in the tumor 
vessels can be demonstrated. Different image acqui-
sition techniques have also been applied to US
examinations. In this article, advances in US tech-
niques are reviewed, and the vascular pattern of
different focal hepatic lesions and their application
to differential diagnosis are discussed.
Advances in US
Conventional grayscale ultrasound
In the 20th century, grayscale US was applied to
the liver and other abdominal organs instead of the
original B-scan US. Grayscale US has been shown
to have higher specificity and accuracy than
scintigraphy in hepatic tumors [2] and provides a
complementary role to radioisotope scanning in
the differential diagnosis of hepatic lesions, including
neoplasms, benign cysts and liver abscesses [1].
Besides visualization of liver anatomy [3] and the
detection of intrahepatic vessels [4], grayscale US
has also been used to detect and evaluate hepatic
tumors and provide complementary information
to scintigraphy and computed tomography (CT)
[5]. Grayscale US provided effective differentiation
between solid tumors and cystic tumors. With tech-
nological advances, real-time US became more effec-
tive and efficient in the examination of the liver.
Using a combination of needle aspiration biopsy
and CT or real-time US, the diagnosis of focal he-
patic lesions was satisfactory for both benign and 
malignant lesions [6]. In a prospective study in 1985
by Sheu et al, real-time US was sensitive in the early
detection of HCC [7]. Besides HCC, various kinds of
hepatic tumors, such as echinococcal cysts [8], focal
nodular hyperplasia [9], hepatic adenoma [10],
nodular regenerative hyperplasia and metastatic
tumors [11], were characterized by US image find-
ings. However, it was still difficult to achieve a sat-
isfactory result in the differential diagnosis of hepatic
tumors using conventional grayscale US alone.
Doppler ultrasound
Although conventional grayscale US is cost efficient
and easily performed in clinical practice, its diagnos-
tic accuracy is less than that of other imaging modal-
ities, such as CT and magnetic resonance imaging
(MRI) [12]. Fortunately, diagnostic accuracy has
increased because of advances in equipment and
the application of color and power Doppler US.
Doppler US with color-coded flow signaling was
developed and introduced into clinical practice in
1980 [13]. By coloring the estimated mean Doppler
frequency shift at a specific location, local blood
flow and vasculature of the target lesion could be
demonstrated. Different vascular patterns were
observed in different kinds of focal hepatic tumors;
thus, the detection of tumor vasculature can aid in
differential diagnoses. Color Doppler US (CDUS) also
provided the opportunity to detect smaller vascu-
lature than that detected by noninvasive CT and MRI
[14]. However, the detection ability of this tech-
nique is insufficient, as only major vessels could be
shown by CDUS. Vessels of small caliber or with
slower blood flow could not be shown by CDUS.
Power Doppler US (PDUS) encoding the power in
color Doppler signals was subsequently invented
and was shown to have higher sensitivity in blood
flow detection and was less angle-dependent than
CDUS [15]. The random noise with low power can
be decreased and no alias will be detected in PDUS.
Although the sensitivity of PDUS is higher than that of
CDUS, especially for HCC [16], hepatic adenoma,
focal nodular hyperplasia [16,17], cholangiocarci-
noma, metastatic tumors and hemangioma [16],
slow blood flow is still difficult to demonstrate.
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Besides CDUS and PDUS, an advanced dynamic
imaging technique has also been used to demon-
strate vasculature. Dynamic flow imaging is a wide-
band Doppler imaging technique where artifacts
can be eliminated. A higher sensitivity for vascular
signals and clearer images can be obtained for
analysis. In addition, when combined with contrast-
enhanced US, advanced dynamic flow imaging can
provide better depiction of tumor vascularity and
help in the diagnosis and assessment of the thera-
peutic effect of radiofrequency ablation [18].
Using color or power Doppler, or advanced
dynamic flow techniques, only major vessel signals
can be identified. According to the vascular patterns
present in hepatic tumors, the vascularity of the
tumors can be divided into hypervascular and hypo-
vascular, which are helpful in the differential diag-
nosis of hepatic tumors (Table). When intratumoral
vessels and/or prominent vascular signal spots are
present, the vascular pattern of the tumor is desig-
nated as hypervascular. When no intratumoral ves-
sels and only peritumoral vessels and/or spotty
intratumoral signals are found, the tumor is desig-
nated as hypovascular.
Contrast-enhanced ultrasound
Contrast agents administered via the intravenous
route introduced to increase the reflectivity of blood
were applied to ultrasonography in 1980. Commer-
cially available intravenous contrast agents have been
shown to aid in the detection of slow (capillary) flow,
which could not be demonstrated by previous color
or power Doppler US techniques. Besides the vas-
cular patterns demonstrated by CDUS and PDUS,
contrast-enhanced US (CEUS) provided capillary
signals and their dynamic changes in whole hepatic
tumors. Therefore, in addition to the hypervascular
or hypovascular characteristics of hepatic tumors,
dynamic changes in enhancing patterns could be
demonstrated by CEUS, which were similar to CT
and MRI.
An US contrast agent is composed of a central
microbubble and an outer stabilizing shell. Many
contrast agents were developed with different types
of central microbubbles and shell combinations.
Increased signal-to-noise ratio helps CEUS to achieve
higher sensitivity in the blood flow signal and better
information on vascularity. Two major generations
of contrast agents have been designated. First-
generation contrast agents spread around the blood
and tissues nonspecifically. These contrast agents
are quickly destroyed by (high mechanical index)
US beams, and only a short duration (several min-
utes) of enhancement could be maintained. The
technique of flash echo may improve the image
quality and also prolong the image acquisition dura-
tion by intermittent flashes on CEUS using first-
generation contrast agents. In second-generation
contrast agents, blood pool and tissue-specific con-
trast agents were developed, which had higher effi-
cacy and longer duration of vascular depiction.
These new contrast agents have a more flexible
Table. Correlation between the nature of hepatic tumors and vasculature on color/power Doppler ultrasound
Benign Malignant
Hypervascular* (Less common)‡ (More common)‡
Focal nodular hyperplasia Hepatocellular carcinoma
Adenoma Metastatic liver cancers
Hypovascular† (More common)‡ (Less common)‡
Hemangioma Cholangiocarcinoma
Hepatic cysts Metastatic liver cancers
Liver abscess
*Existence of intratumoral vessels and/or prominent intratumoral signal spots in color/power Doppler ultrasound; †no intratumoral vessels, only peritumoral
vessels and/or spotty intratumoral signals in color/power Doppler ultrasound; ‡prevalence of the tumors according to intratumoral vasculature.
shell, which oscillates under low mechanical index
US beams and emits harmonic signals during the
scanning process. Therefore, longer duration and
real-time US examination due to less bubble destruc-
tion can be achieved during low mechanical index
US examination.
First-generation contrast agents, such as the
galactose-based contrast agent (Levovist), improved
intralesion blood flow detection in both benign and
malignant lesions and aided in the differential diag-
nosis of focal hepatic lesions [19,20]. Newer second-
generation agents, such as SonoVue, Definity and
Sonazoid, have been shown to be suitable for low
mechanical index imaging and helpful for HCC
detection [21]. CEUS showed high concordance
with CT or MRI for hepatic tumor detection, espe-
cially for the arterial phase [22]. Various types of
contrast agents have been widely used in the diag-
nosis of focal hepatic lesions and in the follow-up
of tumors receiving local treatment modalities [23].
With the use of contrast agents, US had a compa-
rable sensitivity to CT and MRI scanning [24]. The
use of the contrast agent SonoVue in the examina-
tion of focal hepatic lesions significantly improved
the detection rate (351 lesions versus 250 lesions)
and provided a more complete diagnosis (96% vs.
52% of cases) [25] of these lesions compared to
that without SonoVue.
Three-dimensional (3D) ultrasound
The hypervascular characteristic and the existence
of intratumoral vessels are important in the differ-
ential diagnosis of hepatic tumors. However, in some
situations, it is difficult to confirm these vessels as
intratumoral or peritumoral and to demonstrate
the vasculature comprehensively by conventional
two-dimensional (2D) US. Conventional 2D US has
several limitations, including difficulty in reproduc-
ing in sequence examinations, missing out-of-plane
features, misdiagnosis of marginal tumor vessels as
intratumoral vessels, and difficulty in arbitrary plane-
cut demonstration [26]. Only limited plane-cut views
can be provided by 2D US. 3D US is acquired and
collected by serial plane-cut images and stored 
in digitalized datasets. After reconstruction, both
grayscale and color images can be shown sepa-
rately or in combination by 3D stereotype forms.
Because of advances in image processing, 3D US
can be reproduced and reviewed in any arbitrary
view. The structure of the examined organs and the
vascular structures can be demonstrated more com-
prehensively [26,27]. The potential benefits of 3D
US include: (1) a reduction in the number of miss-
ing out-of-plane features seen in 2D US; (2) any
plane cut of view images; (3) exact localization of
vessels in and around the tumor; (4) opportunity for
repeat reviewing of digitalized stored images; and
(5) demonstration of structure of small-caliber ves-
sels, avoiding misdiagnosis as noise seen in 2D US.
When 3D power Doppler imaging was applied to
assess the vascularity in liver tumors in Ohishi et al’s
study, 3D images evaluated the entire tumor vascu-
lature more easily than 2D US [28]. In the evalua-
tion of HCC, 3D US can provide more information
regarding the pattern of tumor vasculature, and
the findings were comparable with those of angiog-
raphy [29]. 3D power Doppler imaging showed
more intratumoral Doppler signals than 2D images
in more than 70% of lesions [30].
Tissue harmonic imaging, pulse inversion
imaging, and flash echo imaging
In addition to CEUS and 3D US, tissue harmonic
imaging of US was introduced to improve the sig-
nal quality of grayscale US and CDUS. With tech-
nological advances, the harmonic wave of US was
received instead of the original reflected wave-
form. Harmonic signals from the nonlinear propa-
gation of sound waves passing through the tissue
were received, using second, third or even fourth
harmonic waveforms for image formation. Using
this method, side lobes and scattering of the wave-
forms was decreased, and the signal-to-noise ratio
was improved. In a randomized study, tissue har-
monic US provided more information in 14 of 
48 patients (29%), and better image quality than
conventional US [31]. In CEUS, harmonic imaging
exploits the nonlinear behavior of microbubbles but
forces a compromise between image sensitivity and
axial resolution. Thus, pulse inversion imaging was
Differential Diagnosis of Hepatic Tumors
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developed to overcome this compromise. Sequences
of pulses of alternate phase are transmitted into the
tissue, and the summed echoes are acquired for
analysis and image formation. Higher contrast sen-
sitivity and better image resolution were achieved
using pulse inversion imaging than by harmonic
imaging [32].
Flash echo imaging is an intermittent harmonic
imaging system with application to CEUS. Flashes
of intermittent high acoustic power are delivered for
the destruction of accumulated contrast microbub-
bles. Low mechanical index acoustic power is used
for continuous monitoring between flashes. Echo
signals from the bubbles, tissue/lesion perfusions,
and vascular signals can be obtained more effi-
ciently [33] using the flash echo imaging system.
Flash echo imaging may have higher sensitivity than
conventional CDUS and PDUS and have similar
sensitivity to dynamic CT and hepatic angiography.
Flash echo imaging with CEUS is also effective in
evaluating response to ethanol treatment in small
HCCs [34], and radiofrequency ablation of HCC
and liver metastases [18].
Differential Diagnosis of 
Hepatic Tumors
Hepatic tumors can easily be detected using tradi-
tional grayscale US; in addition, non-tumor lesions
such as focal fatty infiltration or sparing of focal fatty
infiltration can be differentiated easily [35,36].
However, the important differential diagnosis of
benign and malignant tumors is still difficult. As
previously described, with the use of CDUS, PDUS
and advanced dynamic flow US, hepatic tumors
can be divided into two main categories depending
on vascular abundance: hypervascular and hypo-
vascular. Using these characteristics, focal hepatic
tumors can be divided into two groups: benign
and malignant (Table). Focal nodular hyperplasia
and hepatic adenoma are the two most commonly
seen benign hypervascular tumors. In contrast,
HCC is the most common hypervascular malig-
nancy of all liver tumors. Some metastatic tumors
are also hypervascular but are not so prevalent. In
addition, few cholangiocarcinomas are hypervascu-
lar when imaged using Doppler US. Hemangioma
is the most common hypovascular benign hepatic
tumor. Hepatic cysts (including simple cyst and
polycystic liver), liver abscesses, pseudo-tumors,
hematoma, and focal fatty change are also benign
hypovascular lesions. Among malignant tumors,
most cholangiocarcinoma and some metastatic liver
cancers have been shown to be hypovascular
tumors. Hypervascularity in CDUS and PDUS studies
is more prevalent in malignant tumors, and hypo-
vascularity is more prevalent in benign tumors.
Besides the vascularity of tumors, some enhance-
ment patterns after contrast agent administration
are characteristics of tumor types. Grayscale US
presentations, vascular patterns and dynamic con-
trast enhancement patterns of these hepatic tumors
are discussed as follows.
Malignant Hypervascular Tumors
HCC
HCC is the most common malignancy in the liver.
In conventional US, HCC has a variable and nonspe-
cific presentation on echo pictures. Most small HCCs
less than 3 cm have been noted to be hypoechoic.
Larger HCCs are hyperechoic, which correlates
pathologically with a mixture of hemorrhage, fibro-
sis and necrosis [37]. As small HCCs grow, US shows
an evolution from hypoechoic to isoechoic and then
to an inhomogeneous hyperechoic pattern [38].
Some overlapping characteristics between HCC
and regenerative nodules and a background of cir-
rhosis makes the diagnosis of HCC more difficult
by conventional US only. With the increased depic-
tion of vascularity detected by CDUS and PDUS,
the accuracy of diagnosis and characterization of
HCC have improved. However, smaller tumors with
faint vascular patterns or tumors in a deep location
make CDUS less sensitive and accurate in the dif-
ferential diagnosis of HCC. With CEUS, the enhance-
ment patterns are improved, and typical patterns
of rapid arterial enhancement and rapid wash-out
J.D. Liang, G.T. Huang, P.M. Yang
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in the portal phase can be demonstrated, similar
to those seen in CT. More than 80% concordance
in tumor vascularity between CEUS with a low
mechanical index level and that of contrast-
enhanced helical CT has been reported [39–41].
Homogeneous hypoechoic images in the portal
phase are present in most HCCs, and isoechoic
images were seen in a few cases. In contrast, regen-
erative nodules and dysplastic nodules show a lower
incidence of hypervascularity on CEUS examination.
In Fracanzani et al’s study of Levovist CEUS, intra-
tumoral enhancement could be detected in six of
21 (28%) nonmalignant tumors (regenerative nod-
ules and dysplastic nodules), compared with 19 of
20 HCCs [42]. In these six nonmalignant tumors,
one was a large regenerative nodule with venous
flow, and the other five were dysplastic nodules with
low-resistance arterial flow. For both small HCCs and
dysplastic nodules, contrast-enhanced PDUS had a
higher diagnostic accuracy than conventional US
and fundamental PDUS [43]. Different patterns of
vasculature including diffuse, basket-like, periph-
eral and central were demonstrated by both PDUS
and 3D US [29,44]. Besides vascular imaging, tu-
mor perfusion and liver perfusion imaging using
contrast-enhanced PDUS have also provided tumor
characteristics for differential diagnosis. Whole en-
hancement patterns in tumor perfusion imaging and
whole defect patterns in liver perfusion imaging are
characteristic of moderate and poorly differentiated
HCC [45].
Metastatic liver tumors
Some metastatic tumors are hypervascular in
pathology and US examinations. Some intra- and
peritumoral vascular signals can be identified by
CDUS and PDUS. Mosaic or inhomogeneous
enhancement may be seen using CEUS. The most
common hypervascular metastatic liver cancers
are renal cell carcinoma, transitional cell carcinoma,
carcinoid, choriocarcinoma, islet cell carcinoma,
and papillary cell carcinoma of the pancreas [11].
Therefore, differential diagnosis in these tumors is
difficult and should be based on the prevalence of
clinical data.
Benign Hypervascular Tumors
Focal nodular hyperplasia
Focal nodular hyperplasia (FNH) is an uncommon
benign tumor of the liver with an incidence of 1–3%
and predominantly occurs in women [46]. FNH or
hepatic adenomas are represented by a solid mass
or a mass containing sonolucent areas with hem-
orrhage or necrosis on grayscale US [10]. However,
FNH on conventional US has nonspecific echogenic-
ity with a homogeneous isoechoic or slightly hyper-
or hypoechoic echo picture. The acoustic charac-
teristics of the tumor are similar to the surrounding
normal liver [9]; therefore, it is difficult to differ-
entiate FNH from other types of tumors using 
conventional grayscale US.
A central radiating spoke-wheel arterial pattern
of vessels is characteristic of FNH and can be
demonstrated by CDUS or PDUS. Administration
of contrast agent improves the detection of feed-
ing vessels and the radiating spoke-wheel vascular
pattern [47]. Strong arterial phase and (early) 
portal venous phase enhancement of FNH can 
be observed in low mechanical index level CEUS 
or pulse inversion harmonic studies [48]. The
enhancement may persist, and echo enhancement
is isoechoic or even hyperechoic at the late phase
in CEUS [48,49]. Central scars may also be seen on
CEUS with unenhanced hypoechoic characteristics
[47,50].
Adenoma
Hepatic adenomas are related to oral contraceptives
(hormones) in pathogenesis and are predominant
in women. Hepatic adenomas are well-demarcated
with hypoechoic or hyperechoic characteristics on
grayscale US. Intratumoral fat accounts for this
variation. Non-specific Doppler US signals may be
detected in the tumor. In a prospective study of
hepatic adenomas, CDUS showed intratumoral veins
and peritumoral arteries and veins, which were cor-
related with pathologic examination and provided
clues for differential diagnosis of hepatic adenomas
from focal nodular hyperplasia [51]. In contrast to
FNH with enhancement at arterial and early portal
venous phases, adenomas show homogeneous
enhancement during the arterial phase and no
enhancement could be demonstrated during the
portal venous phase on CEUS. [48]
Malignant Hypovascular Tumors
Cholangiocarcinoma
Cholangiocarcinoma is ranked as the second most
common hepatic malignancy. In peripheral-type
cholangiocarcinoma, more than half of these tumors
are hyperechoic on conventional US and one-third
had a peripheral hypoechoic rim or peripheral bile
duct dilatation [52]. Associated biliary structure
dilatation may be seen and provides a hint for the
diagnosis of cholangiocarcinoma, although this is
not pathognomonic. Most cholangiocarcinomas are
relatively hypovascular on CDUS and PDUS, and
only a few have intratumoral vascular signals. Peri-
tumoral vessels could be identified by color and
PDUS. Intrahepatic cholangiocarcinoma showed
peripheral hyperechoic enhancement in the arte-
rial phase of CEUS and was hypoechoic (wash-out)
in the portal venous phase [53].
Metastatic tumors
Metastases of hepatic tumors mostly originate from
the gastrointestinal tract (especially the colon), lungs,
and breast. The common routes for metastatic liver
tumors are the blood stream (portal venous system,
hepatic artery), lymphatic drainage and, less fre-
quently, from direct invasion. Multiple scattered
nodules in both lobes of the liver are characteristic
for metastatic liver tumors. Calcification of metasta-
tic lesions is another characteristic feature and is
more frequently associated with colon origin [54].
Grayscale US has various different patterns: discrete
echogenic pattern, discrete hypoechoic, anechoic
and diffuse inhomogeneity [11]. Diagnostic accu-
racy of metastatic tumors using US is about 84%
[55]. However, the ultrasound pattern does not
provide enough information to confirm the origin
of the metastasis. Echotexture can be hyperechoic,
isoechoic or hypoechoic. A hypoechoic rim or
sonographic halo sign can sometimes be observed
in the ultrasound study, which is due to parenchy-
mal compression by pathologic features [56]. Some
metastatic tumors have cystic components; there-
fore, differential diagnosis with other cystic lesions
should be carried out. Wall thickness, mural nodules,
septation and the fluid–fluid level on ultrasound are
used to differentiate metastasis from simple cysts [57].
The vascularity of metastatic liver tumors vary;
some are hypervascular, and most, however, are
hypovascular. Hypervascular metastatic tumors 
are mostly hyperechoic and vice versa on grayscale
US [58]. The most frequently observed Doppler 
US pattern is hypovascular with peripheral signal
(66.7% and 83.3% in tumors of 1–4cm and 1–2cm,
respectively) in Gaiani et al’s study [59]. Intranodular
and diffuse vascular signals could only be detected
in one-third and one-sixth of tumors of sizes 1–4 cm
and 1–2 cm, respectively [59]. PDUS demonstrates
vasculature better than CDUS in metastatic lesions;
PDUS demonstrated 18 of 20 metastatic tumors of
1–4 cm in Hosten et al’s study [16]. However, in 12
of 18 detected metastases, vasculature was located
at the periphery and was intranodular in one of 18.
The diffuse vasculature in metastases (27.7%) is
lower than that of other hypervascular tumors such
as HCC (36%) or FNH (52.8%). In addition, the
contrast agent Levovist improved the detectability
of vasculature by US in Hosten et al’s study from 12
of 19 (peripheral flow signal) metastases without
contrast agent to 17 of 19 (two at center and 15 at
periphery) metastases after contrast administration
[16]. CEUS in combination with phase inversion
mode also significantly improved the diagnosis and
characterization of metastases from 63 to 91% [60].
Hepatic lymphoma and leukemia
Lymphoma or leukemia with liver involvement is
rare. The most common ultrasonographic pattern of
hepatic lymphoma is that of hypoechoic, although
diffuse hypoechoic, patterns; target and echogenic
patterns have been reported [61]. Leukemia with
liver involvement may present as multiple hypo- to
anechoic solid masses without acoustic enhance-
ment. A “bull’s-eye” appearance with a hyperechoic
J.D. Liang, G.T. Huang, P.M. Yang
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dense center due to tumor necrosis may also be
present on US [62].
Benign Hypovascular Tumors
Hemangioma
Capillary hemangioma is the most common benign
tumor of the liver. A capillary hemangioma is rep-
resented as a round or irregular shaped, single or
multiple lesions with varying size. These lesions are
mostly homogeneously hyperechoic with sharp
margins, or hypoechoic with or without a hypere-
choic rim on grayscale US. Posterior acoustic
enhancement is more frequently present in heman-
giomas of larger size [63]. Heterogeneous echo-
texture with hypoechoic portions may be seen in
hemangioma due to necrosis, hemorrhage, throm-
bosis or fibrotic scarring [64]. Inhomogeneous
enhancement of these portions may be seen in the
late phase of contrast US [64]. Incidences of hypoe-
choic halo, posterior attenuation and calcification
are low. Large hemangiomas are usually heteroge-
neous in echotexture and may have a central scar.
On CDUS and PDUS, intratumoral vessels are
not present, and only rarely are intralesional vascular
spots seen. An increase in the rate of central spots
has been observed following injection of the first-
generation contrast agent Levovist [16]. However,
this vascular pattern is nonspecific and has a low
accuracy when compared with other imaging
modalities such as CT or MRI [65]. With advances
in contrast agents and US techniques, typical ini-
tial marginal rim or nodular enhancement in the
arterial phase and central filled-in patterns, and
delayed homogeneous enhancement in the portal
phase can be demonstrated by CEUS [66,67], similar
to those in contrast CT and MRI.
Cystic lesions
Tissue fluid, including blood, is anechoic on US.
Cystic lesions of liver were reported with grayscale
US as early as 1978 [68]. Simple cysts are common
on US examinations with an incidence of 1–4%. A
prevalence of 3.6% in a survey of 3,600 patients
was reported in southern Taiwan [69]. Cysts can be
single or multiple, with or without septa. Numerous
cystic lesions are found in polycystic liver disease,
which is commonly associated with polycystic 
kidney disease in patients with autosomal dominant
hereditary predisposition. These benign cystic lesions
are anechoic with thin walls and acoustic enhance-
ment on grayscale US [68,70]. When bleeding or
infection occurs in these cysts, the inner echogenic-
ity increases and becomes heterogeneous in appear-
ance. No vascular flow was detected in these cystic
lesions. The diagnostic accuracy of ultrasound is
high in these lesions and can be up to 95–100%
[70]. Among the cystic lesions, differential diag-
nosis includes simple cysts, necrotic metastases,
echinococcal cysts, hematoma, abscesses, and
hepatic cystadenocarcinoma. Cystadenocarcinoma
should be considered when multiloculated cystic
lesions are noted with local thickening of the septa
with a solid component [71,72]. In contrast, cys-
tadenomas have thin and smooth walls. The pres-
ence of color signals in the solid part of cystic lesions
provides diagnostic information for the differentia-
tion of simple cysts and abscesses [73]. CEUS is also
helpful in demonstrating the mural nodulation or
wall thickening of cystic lesions.
Liver abscess
Infection of the liver may cause abscess formation,
including pyogenic, amebic and candidal liver
abscesses. In pyogenic liver abscesses, the US fea-
tures include: (1) variable size, (2) right lobe abscess
(more common), (3) variable shape (mostly round),
(4) single or multiple, (5) irregular and poorly delin-
eated abscess wall, (6) echotexture from anechoic
to hyperechoic (mostly with lower echogenicity),
and (7) acoustic enhancement of varying degree
[74,75]. Among these features, acoustic enhance-
ment is the most important diagnostic feature in
the differential diagnosis of liver abscesses. A liver
abscess appears as a solid or fluid-filled cystic mass
with variable internal echogenicity [76]. Intra-abscess
gas formation may cause a marked increase in
echogenicity of the abscess. No vascular structures
are detected on CDUS. On contrast enhancement,
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the abscess margin can be irregular and unevenly
enhanced.
In amebic liver abscess, US presentations are
numerous in the literature. US features suggestive
of the diagnosis include: (l) lack of wall echoes, 
(2) round or oval in shape, (3) homogeneous lower
echogenicity, (4) location contiguous with liver
capsule, and (5) distal echo enhancement [77].
Although these features help in the diagnosis, US
findings alone were inadequate in distinguishing
pyogenic from amebic liver abscesses. Amebic liver
abscess diagnosis is confirmed by serum indirect
hemagglutination assay. A combination of US find-
ings and clinical as well as laboratory data can aid in
the correct diagnosis (86%) and differential diag-
nosis of amebic liver abscess from pyogenic liver
abscess [78].
In immunocompromised/immunodeficiency
hosts and patients receiving chemotherapy or
immunosuppressant therapy, candidal and other
fungal infections are common. The simultaneous
occurrence of abscess formation in both the liver
and the spleen is not uncommon. The fungal abscess
is often multiple in number and of variable size
(often small size) and is hypoechoic on ultrasound
examination. Centrally increased echogenicity may
be seen in some patients as a “bull’s-eye” or “target”
lesions [79].
On CDUS and PDUS, no or sometimes faint
vascular signals can be identified at the margin of
a liver abscess. After contrast agent administration,
the peripheral portion of the abscess becomes het-
erogeneous with mosaic enhancement. Honeycomb
structure and septa formation are also observed 
on CEUS.
Pseudo-tumors
Hepatic pseudo-tumors are normal liver tissue pre-
senting as hypoechoic tumors without halo on
ultrasound and are frequently (75%) observed in a
fatty infiltrated liver. Ultrasonographic characteris-
tics are a missing mass effect, a landscape-like con-
figuration with angulated margins and slender
extensions of hypoechoic tissue, and typical loca-
tions of below the capsule, near the gallbladder
and ventral to the portal veins [80]. In contrast to
the fat-sparing pseudo-tumors, increased focal fatty
infiltration of the liver is represented as a homoge-
neous hyperechogenic tumor. The echotexture of
these fat infiltrated areas is the same as that of the
surrounding liver parenchyma and normal inner
vascular structure.
In pseudo-tumors, no obvious vascular signal
besides the normal organ vasculature is observed
on color or PDUS. Likewise, no particular enhance-
ment pattern on CEUS is demonstrated.
Summary
Conventional grayscale US is a good screening tool
in the detection of focal hepatic tumors. However,
differential diagnosis of tumors is difficult with
conventional US alone because of the variable and
nonspecific presentation of these tumors. CDUS and
PDUS demonstrate the vasculature in and around
the tumor. The prominence of vascularity, charac-
terization and patterns of tumor vasculature provide
clues for differential diagnosis, and contrast agent
enhancement improves the sensitivity of vasculature
detection and characterization. 3D US with har-
monic imaging and pulse inversion imaging pro-
vide additional information and better image quality
to improve differential diagnosis. Using various fea-
tures of focal hepatic lesions, US can be very suc-
cessful in the diagnosis and differential diagnosis
of focal hepatic lesions. US had similar diagnostic
efficacy to that of CT and MRI. A combination of
these imaging modalities may allow for easy and
noninvasive diagnosis of hepatic tumors.
References
1. Taylor KJ, Sullivan D, Rosenfield AT, et al. Gray scale
ultrasound and isotope scanning: complementary
techniques for imaging the liver. AJR Am J Roentgenol
1977;128:277–81.
2. Sullivan DC, Taylor KJ, Gottschalk A. The use of ultra-
sound to enhance the diagnostic utility of the equivocal
liver scintigraph. Radiology 1978;128:727–32.
3. Taylor KJ, Carpenter DA, Hill CR, et al. Gray scale
ultrasound imaging. The anatomy and pathology of
the liver. Radiology 1976;119:415–23.
4. Chafetz N, Filly RA. Portal and hepatic veins: accu-
racy of margin echoes for distinguishing intrahepatic
vessels. Radiololgy 1979;130:725–8.
5. Petasnick JP, Ram P, Turner DA, et al. The relation-
ship of computed tomography, gray-scale ultrasonog-
raphy and radionuclide imaging in the evaluation of
hepatic masses. Semin Nucl Med 1979;9:8–21.
6. Whitmire LF, Galambos JT, Phillips VM, et al. Image-
guided percutaneous hepatic biopsy: diagnostic accu-
racy and safety. J Clin Gastroenterol 1985;7:511–5.
7. Sheu JC, Sung JL, Chen DS, et al. Early detection of
hepatocellular carcinoma by real-time ultrasonogra-
phy. A prospective study. Cancer 1985;56:660–6.
8. Lewall DB, McCorkell SJ. Hepatic echinococcal cysts:
sonographic appearance and classification. Radiology
1985;155:773–5.
9. Majewski A, Gratz KF, Brolsch C, et al. Sonographic
pattern of focal nodular hyperplasia of the liver. Eur J
Radiol 1984;4:52–7.
10. Sandler MA, Petrocelli RD, Marks DS, et al. Ultra-
sonic features and radionuclide correlation in liver
cell adenoma and focal nodular hyperplasia. Radiology
1980;135:393–7.
11. Viscomi GN, Gonzalez R, Taylor KJ. Histopatho-
logical correlation of ultrasound appearances of liver
metastases. J Clin Gastroenterol 1981;3:395–400.
12. Whalen E. Liver imaging—current trends in MRI, CT,
and US: international symposium and course, June
1990. AJR Am J Roentgenol 1990;155:1125–32.
13. Middleton WD, Middleton MA. Color Doppler ultra-
sonography. Curr Opin Radiol 1990;2:229–36.
14. Hosten N, Puls R, Bechstein WO, et al. Focal liver
lesions: Doppler ultrasound. Eur Radiol 1999;9:
428–35.
15. Rubin JM. Power Doppler. Eur Radiol 1999;9(Suppl 3):
S318–22.
16. Hosten N, Puls R, Lemke AJ, et al. Contrast-
enhanced power Doppler sonography: improved
detection of characteristic flow patterns in focal liver
lesions. J Clin Ultrasound 1999;27:107–15.
17. Bartolozzi C, Lencioni R, Paolicchi A, et al.
Differentiation of hepatocellular adenoma and focal
nodular hyperplasia of the liver: comparison of
power Doppler imaging and conventional color
Doppler sonography. Eur Radiol 1997;7:1410–5.
18. Hotta N, Tagaya T, Maeno T, et al. Advanced dynamic
flow imaging with contrast-enhanced ultrasonography 
for the evaluation of tumor vascularity in liver tumors.
Clin Imaging 2005;29:34–41.
19. Migaleddu V, Virgilio G, Turilli D, et al. Characteri-
zation of focal liver lesions in real time using harmonic
imaging with high mechanical index and contrast
agent Levovist. AJR Am J Roentgenol 2004;
182:1505–12.
20. Maresca G, Barbaro B, Summaria V, et al. Color
Doppler ultrasonography in the differential diagnosis
of focal hepatic lesions. The SH U 508 A (Levovist)
experience. Radiol Med (Torino) 1994;87(5 Suppl 1):
41–9.
21. Barr R; ATL/Philips Ultrasound. Seeking consensus:
contrast ultrasound in radiology. Eur J Radiol 2002;
41:207–16.
22. Burns PN, Wilson SR. Focal liver masses: enhance-
ment patterns on contrast-enhanced images: con-
cordance of US scans with CT scans and MR images.
Radiology 2007;242:162–74.
23. Kudo M. New sonographic techniques for the diag-
nosis and treatment of hepatocellular carcinoma.
Hepatol Res 2007;37(Suppl 2):S193–9.
24. Nielsen MB, Bang N. Contrast enhanced ultrasound
in liver imaging. Eur J Radiol 2004;51(Suppl):S3–8.
25. Bleuzen A, Huang C, Olar M, et al. Diagnostic accu-
racy of contrast-enhanced ultrasound in focal lesions
of the liver using cadence contrast pulse sequencing.
Ultraschall Med 2006;27:40–8.
26. Downey DB, Fenster A, Williams JC. Clinical utility of
three-dimensional US. Radiographics 2000;20:559–71.
27. Pretorius DH, Nelson TR, Jaffe JS. Three-dimensional
sonographic analysis based on color flow Doppler
and gray scale image data: a preliminary report. 
J Ultrasound Med 1992;11:225–32.
28. Ohishi H, Hirai T, Yamada R, et al. Three-dimensional
power Doppler sonography of tumor vascularity. 
J Ultrasound Med 1998;17:619–22.
29. Liang JD, Yang PM, Liang PC, et al. Three-dimensional
power Doppler ultrasonography for demonstrating
associated arteries of hepatocellular carcinoma. 
J Formos Med Assoc 2003;102:367–74.
30. Xu HX, Liu L, Lu MD, et al. Three-dimensional power
Doppler imaging in depicting vascularity in hepato-
cellular carcinoma. J Ultrasound Med 2003;22:1147–54.
31. Hann LE, Bach AM, Cramer LD, et al. Hepatic
sonography: comparison of tissue harmonic and
standard sonography techniques. AJR Am J Roentgenol
1999;173:201–6.
32. Burns PN, Wilson SR, Simpson DH. Pulse inversion
imaging of liver blood flow: improved method for 
Differential Diagnosis of Hepatic Tumors
267J Med Ultrasound 2007 • Vol 15 • No 4
characterizing focal masses with microbubble con-
trast. Invest Radiol 2000;35:58–71.
33. Kamiyama N, Moriyasu F, Mine Y, et al. Analysis of
flash echo from contrast agent for designing optimal
ultrasound diagnostic systems. Ultrasound Med Biol
1999;25:411–20.
34. Wang JH, Lu SN, Changchien CS, et al. Flash echo
gray scale imaging with subtraction in assessment of
small hepatocellular carcinoma treated with per-
cutaneous ethanol injection: preliminary report. 
J Ultrasound Med 2001;20:539–44.
35. Baker MK, Wenker JC, Cockerill EM, et al. Focal 
fatty infiltration of the liver: diagnostic imaging.
Radiographics 1985;5:923–9.
36. Kissin CM, Bellamy EA, Cosgrove DO, et al. Focal
sparing in fatty infiltration of the liver. Br J Radiol
1986;59:25–8.
37. Sheu JC, Sung JL, Chen DS, et al. Ultrasonography 
of small hepatic tumors using high-resolution 
linear-array real-time instruments. Radiology 1984;
150:797–802.
38. Sheu JC, Chen DS, Sung JL, et al. Hepatocellular 
carcinoma: US evolution in the early stage. Radiology
1985;155:463–7.
39. Giorgio A, Ferraioli G, Tarantino L, et al. Contrast-
enhanced sonographic appearance of hepatocellular
carcinoma in patients with cirrhosis: comparison
with contrast-enhanced helical CT appearance. AJR
Am J Roentgenol 2004;183;1319–26.
40. Bolondi L, Gaiani S, Celli N, et al. Characterization
of small nodules in cirrhosis by assessment of vascu-
larity: the problem of hypovascular hepatocellular
carcinoma. Hepatology 2005;42:27–34.
41. Lee JY, Choi BI, Han JK, et al. State-of-the-art ultra-
sonography of hepatocellular carcinoma. Eur J Radiol
2006;58:177–85.
42. Fracanzani AL, Burdick L, Borzio M, et al. Contrast-
enhanced Doppler ultrasonography in the diagnosis
of hepatocellular carcinoma and premalignant lesions
in patients with cirrhosis. Hepatology 2001;34:1109–12.
43. Rickes S, Schulze S, Neye H, et al. Improved diagnosis
of small hepatocellular carcinoma by echo-enhanced
power Doppler sonography in patients with cirrho-
sis. Eur J Gastroenterol Hepatol 2003;15:893–900.
44. Jung EM, Kubale R, Jungius KP, et al. Vascularization
of liver tumors: preliminary results with coded 
harmonic angio (CHA), phase inversion imaging, 
3D power Doppler and contrast medium-enhanced
B-flow with second generation contrast agent
(Optison). Clin Hemorheol Microcirc 2006;34:483–97.
45. Suzuki Y, Fujimoto Y, Hosoki Y, et al. Clinical utility 
of sequential imaging of hepatocellular carcinoma by
contrast-enhanced power Doppler ultrasonography.
Eur J Radiology 2003;48:214–9.
46. Wanless IR, Mawdsley C, Adams R. On the patho-
genesis of focal nodular hyperplasia of the liver.
Hepatology 1985;5:1194–200.
47. Yen YH, Wang JH, Lu SN, et al. Contrast-enhanced
ultrasonographic spoke-wheel sign in hepatic focal
nodular hyperplasia. Eur J Radiol 2006;60:439–44.
48. Dietrich CF, Schuessler G, Trojan J, et al. Differen-
tiation of focal nodular hyperplasia and hepatocellu-
lar adenoma by contrast-enhanced ultrasound. Br J
Radiol 2005;78:704–7.
49. von Herbay A, Vogt C, Haussinger D. Late-phase
pulse-inversion sonography using the contrast agent
Levovist: differentiation between benign and malig-
nant focal lesions of the liver. AJR Am J Roentgenol
2002;179:1273–9.
50. Ungermann L, Elias P, Zizka J, et al. Focal nodular
hyperplasia: spoke-wheel arterial pattern and other
signs on dynamic contrast-enhanced ultrasonogra-
phy. Eur J Radiol 2007;63:290–4.
51. Golli M, Van Nhieu JT, Mathieu D, et al. Hepatocellu-
lar adenoma: color Doppler US and pathologic cor-
relations. Radiology 1994;190:741–4.
52. Wibulpolprasert B, Dhiensiri T. Peripheral cholan-
giocarcinoma: sonographic evaluation. J Clin Ultra-
sound 1992;20:303–14.
53. Fan ZH, Chen MH, Dai Y, et al. Evaluation of primary
malignancies of the liver using contrast-enhanced
sonography: correlation with pathology. AJR Am J
Roentgenol 2006;186:1512–9.
54. Bruneton JN, Ladree D, Caramella E, et al. Ultrasono-
graphic study of calcified hepatic metastases.
Gastrointest Radiol 1982;7:61–3.
55. Schreve RH, Terpstra OT, Ausema L, et al. Detec-
tion of liver metastases. A prospective study com-
paring liver enzymes, scintigraphy, ultrasonography
and computed tomography. Br J Surg 1984;71:
949–9.
56. Wernecke K, Henke L, Vassallo P, et al. Pathologic
explanation for hypoechoic halo seen on sonograms
of malignant liver tumors: an in vitro correlative
study. AJR Am J Roentgenol 1992;159:1011–6.
57. Federle MP, Filly RA, Moss AA. Cystic hepatic neo-
plasms: complementary roles of CT and sonography.
AJR Am J Roentgenol 1981;136:345–8.
58. Rubaltelli L, Del Maschio A, Candiani F, et al. 
The role of vascularization in the formation of 
J.D. Liang, G.T. Huang, P.M. Yang
268 J Med Ultrasound 2007 • Vol 15 • No 4
Differential Diagnosis of Hepatic Tumors
269J Med Ultrasound 2007 • Vol 15 • No 4
echographic patterns of hepatic metastases:
microangiographic and echographic study. Br J Radiol
1980;53:1166–8.
59. Gaiani S, Casali A, Serra C, et al. Assessment of vascu-
lar patterns of small liver mass lesions: value and limi-
tation of the different Doppler ultrasound modalities.
Am J Gastroenterol 2000;95:3537–46.
60. Albrecht T, Hoffmann CW, Schmitz SA, et al. Phase-
inversion sonography during the liver-specific late
phase of contrast enhancement: improved detection
of liver metastases. AJR Am J Roentgenol 2001;176:
1191–8.
61. Ginaldi S, Bernardino ME, Jing BS, et al. Ultrasono-
graphic patterns of hepatic lymphoma. Radiology
1980;136:427–31.
62. Lepke R, Pagani JJ. Sonography of hepatic chloromas.
AJR Am J Roentgenol 1982;138:1176–7.
63. Taboury J, Porcel A, Tubiana JM, et al. Cavernous
hemangioma of the liver studied by ultrasound.
Enhancement posterior to a hyperechoic mass as a
sign of hypervascularity. Radiology 1983;149:781–5.
64. Vilgrain V, Boulos L, Vullierme MP, et al. Imaging of
atypical hemangiomas of the liver with pathologic
correlation. Radiographics 2000;20:379–97.
65. Kim TK, Han JK, Kim AY, et al. Limitations of charac-
terization of hepatic hemangiomas using a sono-
graphic contrast agent (Levovist) and power Doppler
ultrasonography. J Ultrasound Med 1999;18:737–43.
66. Kim JH, Kim TK, Kim BS, et al. Enhancement of
hepatic hemangiomas with Levovist on coded har-
monic angiographic ultrasonography. J Ultrasound Med
2002;21:141–8.
67. Lee JY, Choi BI, Han JK, et al. Improved sonographic
imaging of hepatic hemangioma with contrast-
enhanced coded harmonic angiography: comparison
with MR imaging. Ultrasound Med Biol 2002;28:287–95.
68. Weaver RM Jr, Goldstein HM, Green B, et al. Gray
scale ultrasonographic evaluation of hepatic cystic
disease. AJR Am J Roentgenol 1978;130:849–52.
69. Huang JF, Chen SC, Lu SN, et al. Prevalence and size
of simple hepatic cysts in Taiwan: community- and
hospital-based sonographic surveys. Gaoxiong Yi Xue
Ke Xue Za Zhi 1995;11:564–7.
70. Spiegel RM, King DL, Green WM. Ultrasonography
of primary cysts of the liver. AJR Am J Roentgenol
1978;131:235–8.
71. Forrest ME, Cho KJ, Shields JJ, et al. Biliary cystade-
nomas: sonographic-angiographic-pathologic corre-
lations. AJR Am J Roentgenol 1980;135:723–7
72. Carroll BA. Biliary cystadenoma and cystadenocarci-
noma: gray-scale ultrasound appearance. J Clin Ultra-
sound 1978;6:337–40.
73. Liang P, Cao B, Wang Y, et al. Differential diag-
nosis of hepatic cystic lesions with gray-scale and
color Doppler sonography. J Clin Ultrasound 2005;
33:100–5.
74. Kuligowska E, Connors SK, Shapiro JH. Liver abscess:
sonography in diagnosis and treatment. AJR Am J
Roentgenol 1982;138:253–7.
75. Newlin N, Silver TM, Stuck KJ, et al. Ultrasonic 
features of pyogenic liver abscess. Radiology 1981;
139:155–9.
76. Wilson SR, Arenson AM. Sonographic evaluation of
hepatic abscesses. J Can Assoc Radiol 1984;35:174–7.
77. Ralls PW, Mikity VG, Colletti P, et al. Sonography in
the diagnosis and management of hepatic abscesses
in children. Pediatr Radiol 1982;12:239–43.
78. Ralls PW, Barnes PF, Radin DR, et al. Sonographic
features of amebic and pyogenic liver abscesses: a
blinded comparison. AJR Am J Roentgenol 1987;149:
499–501.
79. Ho B, Cooperberg PL, Li DKB, et al. Ultrasonography
and computed tomography of hepatic candidiasis in
immunosuppressed patients. J Ultrasound Med 1982;
1:157–9.
80. Hess CF, Kurtz B, Grodd W, et al. Hypoechoic lesions
without halo in echogenic liver. A frequent sono-
graphic dilemma. Acta Radiol 1988;29:541–5.
